The veterinary biopsy needles market size valued USD 762.2 million in 2020 and expected to reach USD 1,367.2 million by 2027, at a CAGR of 6.81% during the forecast period 2021 to 2027. Increased disposable income in emerging countries like India, China is expected to offer lucrative opportunities for the market players due increased adoption of small animals as well as increasing veterinary health care expenditure. This report studies veterinary biopsy needles market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary biopsy needles market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). During biopsy procedures, a needle is used to extract a sample of cells or tissue from the patient’s body for subsequent laboratory testing. When healthcare experts discover aberrant cells or tissues in a patient’s body, they may propose biopsy testing. Biopsy testing helps healthcare practitioners to examine aberrant cells or tissues more closely and pinpoint the underlying illness. A needle biopsy is a procedure that includes inserting a thin needle into the skin to extract a sample of tissue from the tumour location, obviating the need for surgery.